Navigation Links
Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
Date:1/10/2008

took on the role of Senior Advisor to the Foundation in January 2006. Following his diagnoses of prostate cancer in 1995 and Parkinson's disease in 2000, his has become a major voice calling for a "cultural revolution" in biomedical research to speed the delivery of cures. In November 2007 he spoke at the annual meeting of the Society for Neuroscience, arguing that finding new treatments for disease requires different attitudes toward failed experiments and a major rebalancing of research spending.

Mr. Grove's gift will provide a further boost to MJFF's momentum by establishing The Grove Circle, a new planned giving society honoring the Foundation's many friends who plan their estates to support The Michael J. Fox Foundation after their families' needs have been met. More information on The Grove Circle, including benefits of membership and how to become a charter member, is available at http://www.michaeljfox.org.

Deborah W. Brooks, co-founder of MJFF, commented, "The Michael J. Fox Foundation's mission has always been to put itself out of business by curing PD. Needless to say, this key Foundation value is not changing with the establishment of a planned giving effort. Rather, the planned giving established by The Grove Circle's members will provide a major, long-term funding source around which we can plan and which we can leverage immediately to accelerate groundbreaking research."

Founder Michael J. Fox concluded: "Andy has been an incredible benefactor to our Foundation throughout our years of working together. Leave it to him to find one more way to maximize the impact of his generosity and foresight on behalf of PD patients everywhere."

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively f
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
2. Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc.
3. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
4. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
5. Emotional Intelligence and the use of tobacco and cannabis
6. Therap Services to Attend 2nd International Conference on Intellectual Disabilities/Mental Retardation as Gold Sponsor
7. Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit
8. IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities
9. NDMA Launches Clinical Intelligence Platform
10. Turn Competitive Intelligence into a Competitive Edge
11. Depression can foreshadow intellectual decline in older people
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...Ind., Aug. 29 /PRNewswire/ -- Conseco Insurance Co...announced the availability of its new,indexed uni... The policy,provides upside potential with downsid...niversal life policy that offers the,opportunity f...m index,credit of 1%. Clients can customize their ...
(Date:8/29/2008)...Va., Aug. 29 /PRNewswire-USNewswire/ -- The Custom...d today the launch of the Endocrine,Daily Briefing...tigious,Endocrine Society., Endocrine Daily Brief...0 Endocrine Society members, medical professionals...betes and osteoporosis. Endocrine Daily,Briefing j...
(Date:8/29/2008)...ates disappointed that Obama failed to address the...- Speaking at the Democratic,National Convention W...ed,for a reinvigorated response to the domestic HI...Presidential nominee Barack Obama, Clinton said,"...ble global leadership in,an area in which I am dee...
(Date:8/29/2008)...ON, Aug. 29 /PRNewswire-USNewswire/ -- The followi...Campaign for Tobacco-Free Kids:, For the second t...d to,withdraw sponsorship and promotion of a conce...rnational criticism for engaging in cigarette,mark...p Morris International has been forced to withdraw...
Breaking Medicine News(10 mins):Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 3Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...s suffering from tennis elbow ask them to alter th....// A new study evaluating the muscle firing patte... no bearing on the development of tendonitis. Res...p" on the relationship between the development of ...
...has made public its plan of enforcing a ban on smo...ices, cinemas, factories, pubs, bars and such othe... ban.// But the ban does not include outdoors or p...s in England will be required to put up visible “N...
...ey 2005-06 has revealed the extent of spousal viol... injustice meted out to unmarried women. The surve... f 30 organizations who were involved in accumulat...ment in certain categories. Fred Arnold, Vice-Pres...
... needed, especially into the possible genetic and ... in Bhopal exactly// 22 years ago that killed more... subsequent years. Despite the neurological, horm...he survivors are facing besides the genetic damage...
Other Medicine News:Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 2Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 3Health News:Children of Bhopal Gas Victims Suffer from Deformity 2Health News:Children of Bhopal Gas Victims Suffer from Deformity 3
(Date:8/27/2008)...ust 27 /-, - Oralair(R) Gr...Pharmacodynamic Study Conducted in an Allergen Cha...ighly positive results of a new study,conducted in...on Oralair(R) Grasses included 86 adult patients e...eatment durations: 1 week, 1 month,2 and 4 months...
(Date:8/26/2008)...6 /- The Oregon Tourism Commission,la...ervice Training Program,(Q Care) this week on htt...ining program created to support the tourism and,h...ation. By emphasizing,the importance of quality cu...with tools and resources to better serve Oregon,s ...
(Date:8/26/2008)...26 /- Semafore Pharmaceuticals Inc.,p...s on Targeted Therapies,in Cancer in Washington, D...ted kinase inhibitors that demonstrate significant...ovel and proprietary molecular scaffold has been d... the design of pan-PI3 kinase inhibitors,as well a...
(Date:8/26/2008)... 26 /- Cambridge Research &,Instrumen...estro(TM) EX In,Vivo Imaging System. The new syste...ogy and becomes the entry-level instrument of choi...tp://www.newscom.com/cgi-bin/prnh/20080826/NETU054...ancement of CRi,s unique,solid-state tunable optic...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 1Hormonal Changes and Depression 3A What is the Connection 3F 6212 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 3Hormonal Changes and Depression 3A What is the Connection 3F 6212 4Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 1Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 2Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 363 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 163 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 2How much fish have we got 3F 1202 1How much fish have we got 3F 1202 2How much fish have we got 3F 1202 3
...primary and secondary endpoints of,study; no negat...opicitabine and ribavirin ~, CAMBRIDGE, Mass., Jun...ceuticals, Inc. today announced results from a pha...n therapy, consisting of,valopicitabine (NM283), I...epatitis C, pegylated interferon and ribavirin,com...
...07 /PRNewswire/ -- Accera, Inc.,today is presentin...Ib clinical trial of AC-1202 (Ketasyn) in Alzheime...International Conference on,Prevention of Dementia...of earlier clinical and preclinical studies, AC-12...ve the memory and,cognition of subjects of a parti...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value.
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Medicine Products: